Nefiracetam is widely researched for its effects on cognitive performance, mood regulation, and neuroprotection. It belongs to the racetam family but is structurally unique, offering properties that distinguish it from compounds like Piracetam and Aniracetam. Researchers study Nefiracetam for its influence on neurotransmitter systems, memory formation, learning behaviors, and its potential to combat cognitive impairments in neurodegenerative conditions.

• Memory Enhancement Studies
  Nefiracetam has been shown to enhance long-term memory and learning in animal models by promoting synaptic plasticity. It does so by increasing neurotransmission in the hippocampus, a region critical for memory formation.

• Cholinergic and GABAergic Modulation
  It modulates cholinergic activity by enhancing acetylcholine release and receptor sensitivity. Additionally, it positively influences GABA(A) receptors, which can reduce anxiety and support calmness in behavioral models.

• Neurodegenerative Disease Research
  Its neuroprotective effects are of interest in Alzheimer’s disease, Parkinson’s disease, and stroke models. Nefiracetam protects neuronal integrity by regulating calcium channels and intracellular signaling cascades.

• Anti-Anxiety and Mood Regulation
  Unlike other racetams, Nefiracetam demonstrates anxiolytic (anti-anxiety) effects. It reduces stress-induced impairments in cognitive performance, making it a dual-purpose compound for memory and mood research.

• Stroke Recovery Models
  Studies show improved cognitive and motor outcomes when Nefiracetam is used in post-stroke rehabilitation models. It aids in restoring neural activity in damaged brain regions.

• Long-Term Potentiation (LTP) Enhancement
  LTP is a cellular mechanism underlying learning and memory. Nefiracetam facilitates LTP by increasing NMDA receptor sensitivity and influencing calcium-dependent signaling.

• Cognitive Decline Prevention
  It has been investigated as a preventive compound in age-related cognitive decline due to its antioxidant properties and ability to preserve mitochondrial function.

Yes, Nefiracetam is legal to purchase for laboratory and scientific research in most countries. While it is not approved for medical or human consumption, it is not scheduled or banned in major research markets, making it accessible to academic institutions, pharmacologists, and neuroscience labs.

• Not a Controlled Substance in the U.S.
  Nefiracetam is not scheduled under the U.S. Controlled Substances Act, allowing it to be legally purchased and used for non-clinical research.

• Legal in the UK, Canada, and EU for Research
  It remains unscheduled in Canada, the UK, and most of the European Union, provided it is not marketed for human or veterinary consumption.

• For Laboratory Use Only
  All purchases from RC Plug are for research use only. Our labeling and shipping materials reflect this legal classification to avoid customs issues or misuse.

• Researcher and Institutional Use Allowed
  Universities, biotech firms, independent researchers, and cognitive labs are eligible to legally acquire Nefiracetam for controlled experimental settings.

• Not for Dietary or Clinical Use
  It cannot be sold as a supplement, medication, or cognitive enhancer for humans. Doing so would violate health product regulations in nearly all jurisdictions.

• Import Regulations May Vary
  While it is generally legal, researchers should verify with local authorities if any special permits or declarations are needed in specific countries.

Proper storage of Nefiracetam is crucial for maintaining its stability, purity, and effectiveness throughout its shelf life. Like most nootropic research chemicals, Nefiracetam is sensitive to moisture, heat, and light, all of which can degrade the compound over time if not managed correctly.

• Keep in a Cool, Dry Environment
  Store Nefiracetam in a temperature-controlled area, ideally between 2°C and 8°C. Excessive heat can degrade its molecular structure and reduce efficacy in testing.

• Use Airtight Containers
  Exposure to air can introduce moisture and oxidants. Airtight glass or laboratory-grade plastic containers should be used to minimize this exposure.

• Avoid Direct Light Exposure
  Nefiracetam should be kept in amber or opaque containers to block UV and fluorescent light, which can cause photochemical breakdown over time.

• Prevent Humidity Contact
  Moisture is particularly damaging to Nefiracetam’s crystalline structure. Desiccant packets and low-humidity environments are recommended for preservation.

• Label with Date of Opening
  Once a container is opened, researchers should label it with the date to track freshness and avoid using degraded material in future trials.

• Do Not Store in Freezers
  Freezing may cause condensation and alter the powder’s texture or solubility profile. Refrigeration is preferred over freezing.

• Stable for Up to 24 Months
  When stored under proper conditions, Nefiracetam retains its integrity for 2 years from the date of manufacture, ensuring consistent results in long-term studies.

The dosage of Nefiracetam used in scientific studies depends on species, experimental goals, and administration methods. Dosages are calculated based on body weight or concentration in solution, and proper calibration is essential for reproducibility and accuracy in lab settings.

• Rodent Studies (10–100 mg/kg)
  Most rat and mouse studies utilize dosages between 10 and 100 mg per kilogram of body weight. These are typically administered via oral gavage or intraperitoneal injection.

• In Vitro Cell Culture Testing
  For cellular research, concentrations often range from 10–50 μM, depending on the cell type and exposure time. The compound is diluted in DMSO or ethanol.

• Simulated Human Models (100–900 mg/day)
  In hypothetical or computational models representing human pharmacokinetics, dosages between 100 mg and 900 mg per day are explored, divided into 2–3 administrations.

• Dose-Response Analysis
  Research frequently includes a dose-response curve to evaluate how increasing concentrations affect memory, synaptic signaling, or anxiolytic behavior.

• No LD50 at Standard Research Levels
  Nefiracetam has demonstrated a high threshold for acute toxicity in animal models. Lethal doses (LD50) are significantly above those used in studies.

• Tolerance and Receptor Sensitivity
  Some chronic studies show that prolonged high dosing may lead to receptor desensitization, so cyclical or tapered dosing is sometimes employed in long-term trials.

• Solvent Considerations in Dosing
  Nefiracetam must be dissolved properly in compatible solvents before dosing. Incorrect solvent use can affect bioavailability or result interpretation.

Nefiracetam offers a unique combination of cognitive enhancement and mood support, positioning it as a more versatile research compound compared to other racetams. While it shares some similarities with Piracetam and Aniracetam, its pharmacological depth makes it suitable for broader experimental applications.

• Greater Anxiolytic Effect
  Unlike Piracetam and Oxiracetam, which show limited mood influence, Nefiracetam demonstrates strong anxiolytic activity through GABA receptor modulation, making it ideal for mood-cognition crossover studies.

• Higher Potency at Lower Doses
  Nefiracetam requires smaller quantities to achieve noticeable effects in behavior models. This makes it more efficient in studies exploring minimal effective concentrations.

• Longer Duration of Action
  It remains active in test subjects for 6–8 hours, outperforming Aniracetam’s 2–4 hour duration and comparable to Oxiracetam’s moderate duration.

• Dual Mechanism of Action
  Nefiracetam stimulates both cholinergic and GABAergic systems, offering multifaceted support for cognition and emotional regulation, which is not typical in simpler racetams.

• Faster Onset
  It begins to show effects in as little as 30 minutes, which is faster than Piracetam and aligns closely with Aniracetam’s rapid absorption.

• More Lipophilic Structure
  Nefiracetam’s fat solubility allows for better central nervous system penetration, enhancing its effectiveness in brain-targeted experiments.

• Greater Neuroprotective Value
  Its antioxidant and calcium-regulating effects make it particularly useful in models involving oxidative stress or neurodegeneration.

1. Nefiracetam operates through a multifaceted mechanism of action, which differentiates it from simpler racetams. It interacts with various neurotransmitter systems and cellular signaling pathways to promote cognitive function, emotional balance, and neuroprotection. This broad pharmacological profile supports its versatility in experimental research across neuroscience and psychopharmacology.

• Cholinergic Enhancement
  Nefiracetam enhances the release of acetylcholine and improves its receptor binding, especially at muscarinic and nicotinic receptor sites. This activity is essential for memory encoding, attention, and learning behaviors.

• GABA(A) Receptor Modulation
  It positively modulates GABA(A) receptors, promoting inhibitory signaling that contributes to reduced anxiety and improved emotional regulation in animal models.

• Voltage-Gated Calcium Channel Regulation
  The compound increases calcium influx by modulating L-type and N-type calcium channels. Calcium signaling is critical for neurotransmitter release, synaptic strength, and long-term potentiation (LTP).

• Activation of Protein Kinase C (PKC)
  Nefiracetam stimulates PKC pathways, which play a pivotal role in cellular memory consolidation and synaptic plasticity. This contributes to its cognitive-enhancing effects.

• Modulation of NMDA Receptors
  It indirectly increases NMDA receptor sensitivity, supporting excitatory glutamate signaling involved in learning, memory, and synaptic formation.

• Influence on CREB and Neurogenesis
  Emerging research suggests it may promote the activation of CREB (cAMP response element-binding protein), which regulates gene transcription for synaptic growth and neuroplasticity.

• Neuroprotection Against Cytotoxicity
  Nefiracetam has been shown to prevent neuronal death in models of oxidative stress, ischemia, and glutamate-induced cytotoxicity, preserving cellular health during stress conditions.

Nefiracetam exhibits limited water solubility, which is an important consideration in both experimental design and compound preparation. Researchers typically use alternative solvents to ensure accurate dosing and effective bioavailability in laboratory settings.

• Poor Solubility in Water Alone
  The compound dissolves poorly in water, making it unsuitable for aqueous-only preparations without additional solubilizers.

• Readily Soluble in DMSO and Ethanol
  Nefiracetam is highly soluble in dimethyl sulfoxide (DMSO) and ethanol, which are commonly used solvents in biochemical research for accurate solution formulation.

• Requires Proper Dissolution Techniques
  For uniform dispersion, especially in in vitro studies, researchers often use gentle heating or sonication to assist in full solubilization without degradation.

• Use of Surfactants or Co-Solvents
  In some protocols, Nefiracetam is combined with surfactants or emulsifying agents like polyethylene glycol (PEG) or Tween 80 to improve its dispersibility in water-based solutions.

• Solubility Impacts Bioavailability in Vivo
  When used in animal models, the choice of solvent can significantly influence absorption rates and plasma concentration, making solvent selection a key variable in pharmacokinetic studies.

• Stability in Solvent Medium
  Once dissolved in DMSO or ethanol, Nefiracetam remains chemically stable for several hours at room temperature, but refrigeration is recommended for longer storage of solutions.

In its raw research form, Nefiracetam is a white to off-white crystalline powder. Its physical appearance reflects high purity and is one of the first observable indicators of product quality. Variations in texture or color may signal contamination, oxidation, or improper storage.

• Fine, Dry Crystalline Powder
  Nefiracetam is typically provided in a microcrystalline format, which facilitates accurate weighing and easy solution preparation.

• Color Consistency Matters
  The powder should be uniform in appearance, ranging from bright white to light ivory. Any yellowing or discoloration may indicate exposure to moisture or light degradation.

• Odorless and Tasteless (inert form)
  In its pure form, the powder does not emit any notable odor or taste, which is consistent with its classification as a synthetic compound.

• Non-Hygroscopic Under Proper Conditions
  While Nefiracetam does not actively absorb moisture from the air under ideal storage, prolonged exposure to humidity can lead to clumping or partial liquefaction.

• Easy to Measure
  Its low clump factor and even consistency make it suitable for precision microgram or milligram dosing using a calibrated laboratory balance.

• Packaging Format
  At RC Plug, we vacuum-seal the powder in airtight laboratory-grade containers or resealable foil bags to maintain stability during shipping and storage.

Yes, Nefiracetam is designed to efficiently cross the blood-brain barrier (BBB), which is one of the key attributes that makes it a powerful nootropic research compound. Its chemical structure favors lipophilic transport, allowing it to access the central nervous system quickly and directly affect neural pathways.

• Lipophilic Molecular Structure
  Nefiracetam is fat-soluble, which enables passive diffusion through the lipid-rich membrane of the blood-brain barrier.

• Rapid CNS Penetration
  Studies in rodents show that Nefiracetam can be detected in brain tissue within 30 to 60 minutes post-administration, highlighting its ability to reach target regions efficiently.

• Preferential Accumulation in the Hippocampus
  After crossing the BBB, Nefiracetam shows a tendency to localize in the hippocampus and cerebral cortex, regions involved in learning and emotional regulation.

• No Need for Carrier Proteins
  It does not rely on active transporters or specialized proteins to enter the CNS, simplifying its pharmacokinetics and increasing reliability in dosing.

• Supports Immediate Behavioral Effects
  Its ability to act quickly in the brain makes it useful for experiments involving time-sensitive cognitive testing or acute neurochemical analysis.

• Validates Its Use in Central Neurological Models
  The compound’s confirmed BBB permeability is crucial for research into Alzheimer’s disease, stress response, stroke, and other CNS-related conditions.

Although Nefiracetam is not approved for human use, animal studies and in vitro experiments have reported some side effects, mostly at higher dosages. These observations are valuable for researchers assessing the compound’s safety profile and planning dose-response studies.

• Mild Behavioral Changes in Rodents
  Some studies note restlessness, irritability, or increased grooming behaviors when animals are administered high doses. These effects usually reverse after cessation.

• Appetite Suppression
  In a few trials, rodents displayed reduced food intake when administered large doses of Nefiracetam over extended periods, suggesting a potential metabolic side effect.

• Tolerance Development Over Time
  Prolonged use in repeated dosing studies may lead to a decrease in efficacy, possibly due to receptor desensitization or downregulation.

• No Major Toxicological Damage
  Histological examinations of organs and tissues after Nefiracetam administration in standard doses have shown no significant structural abnormalities or toxicity.

• Seizure Threshold Not Affected
  Unlike some other racetams, Nefiracetam does not appear to lower the seizure threshold in animal models, indicating a safer neurological profile.

• Reversible Side Effects
  Behavioral changes, when observed, are typically transient and resolve without intervention once the compound is cleared.

• No Reports of Genotoxicity or Carcinogenicity
  Long-term genotoxicity tests have shown no evidence of DNA damage or tumor formation under standard research conditions.

Chemical identifiers are essential for accurately referencing Nefiracetam in databases, laboratory records, and publications. These identifiers ensure clarity when sourcing, analyzing, or citing the compound in research documentation and cross-referencing with scientific literature.

• CAS Number: 77191-36-7
  The Chemical Abstracts Service (CAS) Registry Number uniquely identifies Nefiracetam and is used by suppliers, customs, and scientific institutions for unambiguous labeling.

• Molecular Formula: C14H18N2O2
  This formula indicates the compound is composed of 14 carbon atoms, 18 hydrogen atoms, 2 nitrogen atoms, and 2 oxygen atoms, which is critical for stoichiometric calculations.

• Molecular Weight: 246.31 g/mol
  The molecular weight aids in preparing accurate molar concentrations for in vitro and in vivo dosing.

• IUPAC Name: N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide
  This systematic name follows IUPAC standards and is required for formal publications, regulatory documentation, and scientific registries.

• PubChem CID: 4434
  Nefiracetam’s compound ID in the PubChem database helps researchers access related data including 3D structure, toxicity, and biological pathways.

• InChI and InChIKey
  These machine-readable chemical identifiers allow databases to interlink with structure-based search engines. Nefiracetam’s InChIKey is ZMQQFBWUKKDJEM-UHFFFAOYSA-N.

• SMILES Notation
  Simplified Molecular Input Line Entry System (SMILES) for Nefiracetam: CC1=C(C(=C(C=C1)NC(=O)CN2CCCC2=O))C — useful for cheminformatics and modeling software.

Yes, one of the core areas of research around Nefiracetam is its direct effect on memory formation and recall mechanisms. It has been repeatedly observed to facilitate learning in animal models through its neurochemical and synaptic activities.

• Enhances Long-Term Potentiation (LTP)
  Nefiracetam strengthens LTP — the process by which synaptic connections become stronger over time, a foundational mechanism of memory consolidation.

• Improves Hippocampal Activity
  The compound increases electrical signaling and neurotransmitter responsiveness in the hippocampus, the brain’s memory center, directly improving spatial and reference memory in studies.

• Boosts Acetylcholine Release
  By enhancing cholinergic transmission, Nefiracetam supports working memory and short-term learning tasks, particularly under stress or distraction.

• Increases NMDA and AMPA Receptor Activity
  These glutamatergic receptors are critical for learning and synaptic plasticity. Nefiracetam sensitizes them, improving the brain’s responsiveness to learning stimuli.

• Promotes Neuronal Firing Consistency
  Studies show increased firing rates and coherence among hippocampal neurons following Nefiracetam administration, correlating with better recall performance.

• Counteracts Memory Impairment
  It reverses scopolamine-induced amnesia and other pharmacologically induced memory disruptions in animal models, indicating protective and restorative properties.

• Reduces Forgetting in Aging Models
  In elderly test subjects, Nefiracetam slows memory decay and improves retention, highlighting its potential for research into age-related cognitive decline.

Yes, combining Nefiracetam with other research agents is common in experimental setups that aim to evaluate synergistic or antagonistic effects. Such “stacking” experiments are used to model real-world complexity in cognitive function and neurotransmitter interactions.

• Combined with Choline Donors
  Nefiracetam is often paired with CDP-Choline or Alpha-GPC to support acetylcholine synthesis. This combination may reduce the likelihood of cholinergic depletion in long-term dosing studies.

• Used in Dual-Racetam Protocols
  It may be co-administered with Aniracetam or Oxiracetam in multi-modal cognitive studies to examine differences in onset, duration, and domain-specific benefits.

• Stacks with Noopept or Phenylpiracetam
  These combinations are used to study additive or contrasting effects in memory enhancement and emotional regulation, especially in neurodegenerative model systems.

• Synergistic Mood-Cognition Studies
  Nefiracetam and L-Theanine or low-dose anxiolytics are sometimes used together to investigate synergistic effects on anxiety and task performance.

• Attention to Dosage Interactions
  When combined, total cognitive receptor engagement can intensify, necessitating adjusted dosages to prevent over-activation or receptor fatigue.

• Solvent Compatibility Is Crucial
  Mixed compound solutions should be tested for stability, as not all racetams share the same solubility or pH tolerances in solvents like DMSO or ethanol.

• Comprehensive Protocol Documentation
  Co-administration requires rigorous tracking of compound sources, administration routes, and timing to avoid misinterpretation of results.

Nefiracetam distinguishes itself through its dual cognitive and mood-enhancing effects, along with a broader spectrum of neurotransmitter interactions than typical racetams. These attributes make it a valuable research target for cognitive neuroscience and psychopharmacology.

• Simultaneous Cognitive and Emotional Modulation
  It uniquely affects both cognitive functions (like memory and learning) and emotional states (like anxiety), offering dual-domain research capabilities.

• Acts on Multiple Neurotransmitter Systems
  While most racetams primarily act through cholinergic pathways, Nefiracetam also modulates GABA, glutamate, and intracellular calcium signaling.

• Higher Potency and Lipophilicity
  Its chemical structure allows for greater bioavailability at lower doses compared to other racetams, and its fat solubility enhances central nervous system absorption.

• Rapid and Long-Lasting
  Nefiracetam has a faster onset (30–60 minutes) and a longer duration (6–8 hours) than most of its analogs, allowing for extended observation periods in trials.

• Anxiolytic Properties
  Few racetams display mood-enhancing or anxiolytic effects; Nefiracetam’s action on GABA(A) receptors gives it a unique profile in stress and anxiety models.

• Enhances Synaptic Plasticity More Robustly
  Compared to Piracetam or Aniracetam, Nefiracetam exerts a stronger influence on LTP and receptor density modulation, which is crucial for neuroplasticity research.

• Suitable for Advanced Cognitive Decline Models
  Its protective and restorative properties make it ideal for use in models of dementia, traumatic brain injury, and stroke recovery, where other racetams fall short.

Yes, Nefiracetam is one of the few racetams shown to reduce anxiety, making it particularly valuable for research into cognitive performance under stress and mood-related disorders. Its anxiolytic properties stem from its interaction with GABA and calcium channels in the brain.

• Modulates GABA(A) Receptors
  GABA is the brain’s main inhibitory neurotransmitter. Nefiracetam enhances GABA(A) activity, resulting in a calming effect without traditional sedative drawbacks.

• Lowers Corticosterone in Stress Models
  Rodents treated with Nefiracetam show reduced blood levels of corticosterone (the rodent equivalent of cortisol), suggesting lowered physiological stress responses.

• Improves Performance Under Pressure
  In learning models involving fear or time constraints, subjects administered Nefiracetam performed better, indicating reduced anxiety-induced cognitive impairment.

• Does Not Induce Sedation
  Unlike benzodiazepines or barbiturates, Nefiracetam reduces anxiety without impairing alertness, motor coordination, or cognitive clarity.

• Potential Applications in PTSD and Social Anxiety Models
  Due to its emotional regulation effects, it’s being explored in trauma and social behavior studies for potential benefits in high-stress environments.

• Synergizes with Other Anxiolytics
  Combined with other mood stabilizers in research, Nefiracetam may enhance overall emotional stability, allowing for multifactorial anxiety reduction trials.

• Effective at Low Doses
  Even at minimal dosages, anxiolytic effects have been documented in animal models, indicating that mood benefits may be achievable without cognitive overstimulation.

Nefiracetam is used by a wide spectrum of scientific professionals for its multifaceted neuropharmacological profile. It supports research in memory enhancement, emotional regulation, synaptic transmission, and neuroprotection. Because of its breadth of action, it is applicable across disciplines, from basic neuroscience to pharmacological modeling.

• Neuroscientists
  These researchers study how Nefiracetam modulates synaptic plasticity, neurotransmitter release, and brain circuit activity involved in cognition and behavior.

• Pharmacologists
  Pharmacologists use Nefiracetam to assess dose-response relationships, toxicity, metabolic profiles, and interactions with other psychoactive compounds.

• Psychologists and Behavioral Scientists
  Behavioral studies involving learning, memory, anxiety, and attention use Nefiracetam to evaluate how cognition changes under experimental stressors or in aged models.

• Neurodegeneration Researchers
  Those studying Alzheimer’s, Parkinson’s, and stroke employ Nefiracetam in preclinical models to explore its neuroprotective and memory-restorative effects.

• Cognitive Scientists and Computational Modelers
  Computational studies on attention and memory simulate Nefiracetam’s influence on cognitive functions within artificial or hybrid neural network systems.

• Biochemists and Molecular Biologists
  These researchers investigate how Nefiracetam influences intracellular pathways like calcium channel regulation, protein kinase activation, and gene expression related to plasticity.

• Clinical Researchers (Preclinical Phase)
  In early preclinical drug development, Nefiracetam is studied as a reference compound for comparison or potential lead optimization due to its well-documented cognitive benefits.